Selected research
Industry Growth & Trends
Global Levosulpiride Industry Growth and Trends Forecast to 2032
Market perspective
The global Levosulpiride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Levosulpiride include Sun Pharmaceutical Industries, Suzhou Chenghe Pharmaceutical & Chemical, Harbin Gloria Pharmaceuticals, Vasoya Industries, New Donghai Pharmaceutical and Bona Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Levosulpiride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Levosulpiride market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Levosulpiride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Levosulpiride.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Levosulpiride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Levosulpiride Market by Company
Sun Pharmaceutical Industries
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Vasoya Industries
New Donghai Pharmaceutical
Bona Chemical
Levosulpiride Segment by Type
Above 98%
Below 98%
Levosulpiride Segment by Application
Tablet
Capsule
Other
Levosulpiride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levosulpiride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levosulpiride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levosulpiride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Levosulpiride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Sun Pharmaceutical Industries
- Suzhou Chenghe Pharmaceutical & Chemical
- Harbin Gloria Pharmaceuticals
- Vasoya Industries
- New Donghai Pharmaceutical
- Bona Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Levosulpiride Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Levosulpiride Sales Estimates and Forecasts (2021-2032)
- 1.3 Levosulpiride Market by Type
- 1.3.1 Above 98%
- 1.3.2 Below 98%
- 1.4 Global Levosulpiride Market Size by Type
- 1.4.1 Global Levosulpiride Market Size Overview by Type (2021-2032)
- 1.4.2 Global Levosulpiride Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Levosulpiride Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Levosulpiride Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Levosulpiride Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Levosulpiride Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Levosulpiride Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Levosulpiride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Levosulpiride Industry Trends
- 2.2 Levosulpiride Industry Drivers
- 2.3 Levosulpiride Industry Opportunities and Challenges
- 2.4 Levosulpiride Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Levosulpiride Revenue (2021-2026)
- 3.2 Global Top Players by Levosulpiride Sales (2021-2026)
- 3.3 Global Top Players by Levosulpiride Price (2021-2026)
- 3.4 Global Levosulpiride Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Levosulpiride Major Company Production Sites & Headquarters
- 3.6 Global Levosulpiride Company, Product Type & Application
- 3.7 Global Levosulpiride Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Levosulpiride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Levosulpiride Players Market Share by Revenue in 2025
- 3.8.3 2025 Levosulpiride Tier 1, Tier 2, and Tier 3
4 Levosulpiride Regional Status and Outlook
- 4.1 Global Levosulpiride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Levosulpiride Historic Market Size by Region
- 4.2.1 Global Levosulpiride Sales in Volume by Region (2021-2026)
- 4.2.2 Global Levosulpiride Sales in Value by Region (2021-2026)
- 4.2.3 Global Levosulpiride Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Levosulpiride Forecasted Market Size by Region
- 4.3.1 Global Levosulpiride Sales in Volume by Region (2027-2032)
- 4.3.2 Global Levosulpiride Sales in Value by Region (2027-2032)
- 4.3.3 Global Levosulpiride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Levosulpiride by Application
- 5.1 Levosulpiride Market by Application
- 5.1.1 Tablet
- 5.1.2 Capsule
- 5.1.3 Other
- 5.2 Global Levosulpiride Market Size by Application
- 5.2.1 Global Levosulpiride Market Size Overview by Application (2021-2032)
- 5.2.2 Global Levosulpiride Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Levosulpiride Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Levosulpiride Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Levosulpiride Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Levosulpiride Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Levosulpiride Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Levosulpiride Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sun Pharmaceutical Industries
- 6.1.1 Sun Pharmaceutical Industries Company Information
- 6.1.2 Sun Pharmaceutical Industries Business Overview
- 6.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sun Pharmaceutical Industries Levosulpiride Product Portfolio
- 6.1.5 Sun Pharmaceutical Industries Recent Developments
- 6.2 Suzhou Chenghe Pharmaceutical & Chemical
- 6.2.1 Suzhou Chenghe Pharmaceutical & Chemical Company Information
- 6.2.2 Suzhou Chenghe Pharmaceutical & Chemical Business Overview
- 6.2.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio
- 6.2.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Developments
- 6.3 Harbin Gloria Pharmaceuticals
- 6.3.1 Harbin Gloria Pharmaceuticals Company Information
- 6.3.2 Harbin Gloria Pharmaceuticals Business Overview
- 6.3.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio
- 6.3.5 Harbin Gloria Pharmaceuticals Recent Developments
- 6.4 Vasoya Industries
- 6.4.1 Vasoya Industries Company Information
- 6.4.2 Vasoya Industries Business Overview
- 6.4.3 Vasoya Industries Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Vasoya Industries Levosulpiride Product Portfolio
- 6.4.5 Vasoya Industries Recent Developments
- 6.5 New Donghai Pharmaceutical
- 6.5.1 New Donghai Pharmaceutical Company Information
- 6.5.2 New Donghai Pharmaceutical Business Overview
- 6.5.3 New Donghai Pharmaceutical Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 New Donghai Pharmaceutical Levosulpiride Product Portfolio
- 6.5.5 New Donghai Pharmaceutical Recent Developments
- 6.6 Bona Chemical
- 6.6.1 Bona Chemical Company Information
- 6.6.2 Bona Chemical Business Overview
- 6.6.3 Bona Chemical Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Bona Chemical Levosulpiride Product Portfolio
- 6.6.5 Bona Chemical Recent Developments
7 North America by Country
- 7.1 North America Levosulpiride Sales by Country
- 7.1.1 North America Levosulpiride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Levosulpiride Sales by Country (2021-2026)
- 7.1.3 North America Levosulpiride Sales Forecast by Country (2027-2032)
- 7.2 North America Levosulpiride Market Size by Country
- 7.2.1 North America Levosulpiride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Levosulpiride Market Size by Country (2021-2026)
- 7.2.3 North America Levosulpiride Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Levosulpiride Sales by Country
- 8.1.1 Europe Levosulpiride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Levosulpiride Sales by Country (2021-2026)
- 8.1.3 Europe Levosulpiride Sales Forecast by Country (2027-2032)
- 8.2 Europe Levosulpiride Market Size by Country
- 8.2.1 Europe Levosulpiride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Levosulpiride Market Size by Country (2021-2026)
- 8.2.3 Europe Levosulpiride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Levosulpiride Sales by Country
- 9.1.1 Asia-Pacific Levosulpiride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Levosulpiride Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Levosulpiride Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Levosulpiride Market Size by Country
- 9.2.1 Asia-Pacific Levosulpiride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Levosulpiride Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Levosulpiride Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Levosulpiride Sales by Country
- 10.1.1 South America Levosulpiride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Levosulpiride Sales by Country (2021-2026)
- 10.1.3 South America Levosulpiride Sales Forecast by Country (2027-2032)
- 10.2 South America Levosulpiride Market Size by Country
- 10.2.1 South America Levosulpiride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Levosulpiride Market Size by Country (2021-2026)
- 10.2.3 South America Levosulpiride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Levosulpiride Sales by Country
- 11.1.1 Middle East and Africa Levosulpiride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Levosulpiride Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Levosulpiride Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Levosulpiride Market Size by Country
- 11.2.1 Middle East and Africa Levosulpiride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Levosulpiride Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Levosulpiride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Levosulpiride Value Chain Analysis
- 12.1.1 Levosulpiride Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Levosulpiride Production Mode & Process
- 12.2 Levosulpiride Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Levosulpiride Distributors
- 12.2.3 Levosulpiride Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst